Oncolytics Biotech completes redomestication to Nevada; adopts new equity plan and governance documents

ONCOLYTICS BIOTECH INC

Redomestication from Canada to Nevada completed; common stock continues trading on Nasdaq under ONCY.
New CUSIP 68237V 103 and ISIN US68237V1035 effective April 1, 2026.
Board adopted 2026 Incentive Award Plan with 6.5M initial shares plus annual evergreen increase up to 6% of outstanding.
New indemnification agreements executed with all executive officers and directors.
Risk factor update warns of reduced stockholder rights under Nevada law, including exclusive forum provisions and no cumulative voting.

item 1.01 item 3.03 item 5.03 item 5.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

ONCOLYTICS BIOTECH INC issued common stock.

Security: common stock

Exact text from the filing

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the "Articles of Domestication"); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the "Articles of Incorporation").

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ONCOLYTICS BIOTECH INC: Filed Articles of Incorporation and adopted Bylaws in connection with domestication from British Columbia to Nevada.

Change: bylaw amendment

Exact text from the filing

On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.

View on SEC.gov

Browse all equity issuances →

ONCOLYTICS BIOTECH INC filing history →

Source: SEC EDGAR

accession 0001104659-26-038272

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.